Although p16 levels are reduced in a variety of malignant tumors, this gene product has been shown to be upregulated (or overexpressed) in the majority of high-grade cervical dysplasias and carcinomas induced by high-risk HPV subtypes (10). The gene discussed is CDKN2A; the disease is cervical intraepithelial neoplasia.